|
|
||||||||
J Thorac Cardiovasc Surg 2002;123:582-583
© 2002 The American Association for Thoracic Surgery
Letters to the Editor |
University of Pennsylvania Medical School
Philadelphia, PA 19104
To the Editor:
The article by Rajnoch and associates
1 and the associated editorial by Weisel and colleagues
2 in the May 2001 issue of the Journal add to a rapidly expanding body of literature assessing the efficacy of "cellular cardiomyoplasty" in preventing or reversing heart failure due to postinfarction left ventricular remodeling.
The implied hypothesis is that cellular cardiomyoplasty replaces cardiac myocytes that have been lost as a result of a myocardial infarction. Although attractive, this idea is relatively naive given what is known about normal myocardium and ventricular remodeling. Two points need clarification.
First, normal myocardium is composed of cardiac myocytes and an intracellular collagen matrix, which are intimately related and necessary for effective cardiac performance. Myocardial infarction destroys both of these tissue types. Myocytes that are implanted randomly into an infarct in the absence of a viable collagen network to "harness them together" are unlikely to provide effective contractile force.
Second, postinfarction left ventricular remodeling results in the insidious development of heart failure over time.
3 Patients are initially hemodynamically compensated, indicating that they have a sufficient number of viable myocytes to maintain adequate cardiac performance. Over time, the remodeling phenomenon results in a myopathic process in normally perfused myocardium that leads to heart failure.
4
Given these two facts, it seems to us that a strategy intended to prevent myocardial impairment resulting from left ventricular remodeling would be superior to one that proposes to restore ventricular function by haphazardly introducing myocytes in an attempt to replace those lost as the result of an infarction.
We hypothesize that the salutary effects attributed to cellular cardiomyoplasty in this study
1 are in reality the result of an alteration in infarct material properties, which prevented infarct expansion, therefore limiting the myopathic effects of postinfarction left ventricular remodeling.
5
The surgical armamentarium for the treatment of patients with heart failure is replete with operations that seemed like good ideas initially but, when introduced clinically, provided inconsistent results. Before yet another procedure is introduced, we should fully understand the problem we are trying to solve and what we can realistically hope to accomplish with the operation.
12/8/120722doi:10.1067/mtc.2002.120722
References
This article has been cited by other articles:
![]() |
M. Rubart, K. B.S. Pasumarthi, H. Nakajima, M. H. Soonpaa, H. O. Nakajima, and L. J. Field Physiological Coupling of Donor and Host Cardiomyocytes After Cellular Transplantation Circ. Res., June 13, 2003; 92(11): 1217 - 1224. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |